Corporate Corruption News Stories

Excerpts of Key Corporate Corruption News Stories in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

In September 2004, Merck, one of America's largest pharmaceutical companies, issued a sudden recall of Vioxx, its anti-pain medication widely used to treat arthritis-related ailments. The recall came just days after Merck discovered that a top medical journal was about to publish a study by an FDA (Food and Drug Administration) investigator indicating that the drug in question greatly increased the risk of fatal heart attacks and strokes and had probably been responsible for at least 55,000 American deaths during the five years it had been on the market. It soon turned out Merck had known of potential lethal side effects even before launching Vioxx in 1999, but had brushed all such disturbing tests under the rug. A class-action lawsuit dragged its way through the courts for years, eventually being settled for $4.85 billion in 2007. [Researcher Ron] Unz makes the point that the users of Vioxx were almost all elderly, and it was not possible to determine whether a particular victim's heart attack had been caused by Vioxx or other factors. But he concludes: "Perhaps 500,000 or more premature American deaths may have resulted from Vioxx, a figure substantially larger than the 3,468 deaths of named individuals acknowledged by Merck during the settlement of its lawsuit. I'm just as astonished. From 2004 onwards, huge numbers of America's toughest trial lawyers were suing Merck for billions based on Vioxx casualties - didn't they notice the dramatic drop in the national death rate [after Vioxx was discontinued]?"

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

No single person has come to more represent the big questions about drug safety that emerged following the withdrawal of Merck's painkiller Vioxx than the Food and Drug Administration's David Graham. And now that a Texas jury has awarded the widow of one Vioxx patient $253 million, Graham, who works in the FDA's Office of Drug Safety, is more critical than ever. Of the drug, and his employer, for whom he doesn't speak. "If the judgment is that there's blood on Merck's hands," Graham says, "there's blood on the FDA's hands as well." Graham has estimated that Vioxx killed some 60,000 patients - as many people, he points out, as died in the Vietnam War. He says that fundamental problems at the FDA led to those deaths. "People should turn to Congress and demand a drug safety system that is free from corporate influence - and a distinct center for drug safety." In Graham's eyes, the problem at the FDA is that the same scientists who approve drugs are the ones charged with deciding whether or not they are safe enough to remain on the market when problems crop up. Graham says that he thinks there should be formal, periodic reviews of the safety of new medicines - and that the FDA should release documents that explain its reasoning. "The FDA does not think anything it did is a mistake," he says. "[Yet] none of its decisions are evidence-based." "Today Merck was on trial, and a judgment was rendered," he says. "But when will the public hold the FDA accountable for its role, its complicity, in this catastrophe?"

Note: Learn how Merck blatantly altered the death numbers in their drug trials in this Seattle Times article. This article persuasively argues the actual death numbers were around 500,000. WTK founder Fred Burks had a shocking encounter where he learned about intense corruption at the FDA. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

The sudden death of a prominent anti-vaccination activist has led to a police probe. Brandy Vaughan, 45, was found dead on December 7. On Monday, the Santa Barbara County Sheriff's Office announced an investigation into the circumstances surrounding her death. "The decedent has been positively identified and the death is believe [sic] to be a result of natural causes based on an autopsy exam conducted last week," Santa Barbara County Sheriff Public Information Officer Raquel Zick said. "The final cause and manner of death determination are pending toxicology screening which normally takes 4-6 weeks." Vaughan, a former Merck pharmaceutical representative, was an outspoken critic of mandatory vaccinations and pharmaceutical companies. She founded non-profit organization Learn The Risk in a bid to educate people "on the dangers of pharmaceutical products, including vaccines and unnecessary medical treatments." [Vaughan] once worked for Merck pharmaceutical as a sales representative for Vioxx, a painkiller eventually taken off the market."I realized that just because something is on the market doesn't mean it's safe," Vaughan writes. "Much of what we are told by the healthcare industry just simply isn't the truth." In a Facebook post dated December 4 of 2019, Vaughan asks: "Ever wonder why I speak out against Big Pharma and suffer the major consequences? Because I will fight for my son and humanity and I will educate people on pharmaceutical product dangers until my last breath!"

Note: This article fails to mention that the number of deaths due to Vioxx are estimated to be between 40,000 and 500,000. Read also an article titled "Mystery surrounds death of Tanzanian president who defied COVID lockdown." For more along these lines, see concise summaries of deeply revealing news articles on vaccines and Big Pharma corruption from reliable major media sources.

Twenty-nine Nobel laureates have condemned alleged "judicial harassment" by Chevron and urged the release of a US environmental lawyer who was put under house arrest for pursuing oil-spill compensation claims on behalf of indigenous tribes in the Amazon. The open letter signed by scientists, authors, environmentalists and human rights activists said the treatment of lawyer Steven Donziger, whose movements have been restricted for more than 250 days, was one of the world's most egregious cases of judicial harassment and defamation. Donziger represents 30,000 indigenous people and small farmers who won a $9.5bn class action lawsuit against Chevron in Ecuadorean courts in 2013, as compensation for the contamination of their land by oil extraction activities. This judgment was one of the largest ever against an oil company, but not a cent of these damages has been paid to the plaintiffs. Donziger, who has been involved with the case for 27 years, has pressed for justice and payment of damages to his clients at increasing personal cost. His reputation, legal credentials and liberty have come under attack. Chevron has lobbied for his removal from bar associations and launched a countersuit accusing him of bribery and fraud, which was upheld by district judge Lewis A Kaplan in 2014. It was later reported that Chevron paid more than a million dollars for one of the key witnesses in the case – an Ecuadorean judge – to come to the United States. That witness later said he lied under oath.

Note: For lots more, read this Mother Jones article titled "How Did a Lawyer Who Took on Big Oil and Won End up Under House Arrest?." For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

On Wednesday, Human Rights Watch released a troubling report, which it has since walked back, about a phone application made by the Chinese government. The app provides law enforcement with easy, daily access to data detailing the religious activity, blood type, and even the amount of electricity used by ethnic minority Muslims living in the western province of Xinjiang. The app relies heavily on facial recognition software supplied by Face++, a division of the Chinese startup Megvii. The flurry of media reports this week about Face++ ... and the role of the private sector in building China's increasingly sprawling surveillance state, however, left out another prominent investor in the company: Hunter Biden. Hunter Biden's investment company in China, known as Bohai Harvest RST, has pooled money, largely from state-owned venture capital, to buy or invest in a range of industries. In 2017, Bohai Harvest bought into Face++. Bohai Harvest ... has brought Hunter Biden into close proximity to influential Chinese government and business figures. The investment fund has also partnered with a subsidiary of HNA Group. The HNA Group has made unusually extensive efforts to cultivate U.S. officials. The company floated an offer to buy out the hedge fund owned by former White House official Anthony Scaramucci; retained the legal services of Gary Locke, the former U.S. ambassador to China, shortly before his confirmation; and provided financing to a private-equity firm backed by Jeb Bush.

Note: While Hunter Biden was indicted for three felony gun charges and nine counts of tax-related crimes, his laptop revealed suspicious business dealings with corrupt overseas firms. This informative video delves into the shady dealings of Hunter Biden. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the corporate world from reliable major media sources.

The latest study to look at the long-term effects of Roundup, a popular weed killer developed by Monsanto in the 1970s, raises questions about the herbicide's possible contributions to poor health in certain communities. The study, published Tuesday in JAMA, tracked people over the age of 50 in southern California from 1993-1996 to 2014-2016, with researchers periodically collecting urine samples during that time. The percentage of people who tested positive for a chemical called glyphosate, which is the active ingredient in the herbicide Roundup, shot up by 500% in that time period. The levels of glyphosate also spiked by 1208% during that time. One trial from the UK, in which rats were fed low levels of glyphosate throughout their lives, found that the chemical contributed to a higher risk of nonalcoholic fatty liver disease, a condition in which fat accumulates in the liver and contributes to inflammation and scarring of the tissue. [Researcher Paul] Mills says that the levels of glyphosate documented in the people in his study were 100-fold greater than those in the rats. While Roundup was developed to eliminate most weeds from genetically modified crops – and thus reduce the amount of pesticides sprayed on them – recent studies have found that many weeds are now resistant to Roundup. That means growers are using more Roundup, which could only exacerbate potential negative health effects on people who consume those products.

Note: Bayer recently agreed to a $10 billion settlement over claims that its glyphosate-containing product RoundUp causes cancer. Meanwhile, Mexico is banning glyphosate and GMO corn. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and GMOs from reliable major media sources.

Monsanto owner Bayer AG and industry lobbyist CropLife America have been working closely with US officials to pressure Mexico into abandoning its intended ban on glyphosate, a pesticide linked to cancer that is the key ingredient in Monsanto's Roundup weedkillers. The moves to protect glyphosate shipments to Mexico have played out over the last 18 months, a period in which Bayer was negotiating an $11bn settlement of legal claims brought by people in the US who say they developed non-Hodgkin lymphoma due to exposure to the company's glyphosate-based products. The pressure on Mexico is similar to actions Bayer and chemical industry lobbyists took to kill a glyphosate ban planned by Thailand in 2019. Records show alarm starting to grow in the latter part of 2019 after Mexico said it was refusing imports of glyphosate from China. In denying a permit for an import shipment, Mexican officials cited the "precautionary principle", which generally refers to a policy of erring on the side of caution. Industry executives told US government officials that they feared restricting glyphosate would lead to limits on other pesticides and could set a precedent for other countries to do the same. Mexico may also reduce the levels of pesticide residues allowed in food, industry executives warned. "If Mexico extends the precautionary principle" to pesticide residue levels in food, "$20bn in US annual agricultural exports to Mexico will be jeopardized", [CropLife president Chris] Novak wrote to US officials.

Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.

The factory that Pfizer Inc. plans to use to boost production of its covid-19 vaccine for the massive U.S. inoculation effort was cited by federal inspectors last year for repeated quality-control violations. Food and Drug Administration inspectors visited the McPherson, Kansas, plant at the end of 2019 into January 2020, according to an inspection report. They found the drug giant released medications for sale after failing to thoroughly review quality issues that arose in routine testing, the report shows. Additionally, the report says inspectors found bacteria and mold in supposedly sterile areas, an issue seen in previous visits to the facility. And the plant failed to properly sample drug products to ensure they didn't have excessive levels of certain toxins, the inspectors wrote. The FDA sent Pfizer a warning letter, the agency's strongest rebuke, concerning the factory in 2017 after the agency detected issues similar to those it found in 2020. The FDA concluded that Pfizer had addressed the violations in June 2018, a month before it returned to the facility and found more problems. The company plans to supply the U.S. with 200 million doses of its two-shot vaccine regimen by the end of May. The FDA halted all inspections of drugmaking facilities at the beginning of the Covid-19 pandemic, though it has since resumed some domestic visits. Pfizer's plant in Kansas is also authorized to make the Covid-19 treatment remdesivir.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma corruption from reliable major media sources.

President Joe Biden's administration is being asked to punish Hungary, Colombia, Chile, and other countries for seeking to ramp up the production of Covid-19 vaccines and therapeutics without express permission from pharmaceutical companies. The sanctions are being urged by the drug industry, which has filed hundreds of pages of documents to the Office of the U.S. Trade Representative outlining the alleged threat posed by any effort to challenge "basic intellectual property protections" in the response to the coronavirus pandemic. The drug industry has sharply criticized any attempt to share vaccine patents or the technological knowledge needed to manufacture them, despite global need. The strident corporate opposition to any intellectual property flexibility has rankled public health advocates, many of whom note that much of the vaccine technology has been financed by the public sector. The Pfizer vaccine, noted Prabhala, was developed in partnership with the European firm BioNTech, which received $445 million from the German government to help accelerate vaccine development and manufacturing. The U.S. government provided about $1 billion for the research and testing by Moderna to create its coronavirus vaccine. Johnson & Johnson received over $1.45 billion in funding from the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services, for its recently approved Covid-19 vaccine.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma corruption from reliable major media sources.

A nursing home accused of illegally "dumping" patients onto city streets and into ill-equipped homes in order to take in more lucrative COVID-19 patients will nearly double its nursing staff, allow increased oversight and pay $275,000 in penalties and costs to settle a lawsuit brought by the Los Angeles city attorney's office. City Attorney Mike Feuer on Monday announced the legal agreement with the Lakeview Terrace skilled nursing facility, which he had accused of "sustained" and "intentional" misconduct in failing to adequately tend to some patients, while pushing others out of the 99-bed home. The city alleged in its lawsuit that the facility west of downtown had an incentive to discharge long-term residents in order to make room for COVID-19 patients, who brought Lakeview Terrace much higher reimbursement payments from Medicare. In one instance, the lawsuit said, an 88-year-old man with dementia was transferred from the nursing home in the Westlake neighborhood to a boarding house in Van Nuys, only to be found a day later wandering the streets, profoundly confused. Health care experts have warned that the money skilled nursing facilities are paid under a plan by the federal government to care for people stricken by the coronavirus would lead to patient-dumping by unscrupulous operators. The reimbursement plan pays more than four times more for COVID-19 patients than homes can charge for long-term residents with relatively mild conditions.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Carlos is a Mexican businessman. Two associates accompanied him as he travelled [to] India. There, [he] met Manu Gupta, a businessman active in a variety of sectors. On 25 September 2018 he was arrested in the city of Indore, Madhya Pradesh, along with a Mexican associate and an Indian chemist. The three men were wearing masks and gloves – and were in possession of more than 10kg of fentanyl – an ultra-potent synthetic opioid. The case sheds light on the international networks which Mexican cartels have built up – and the business methods they employ to dominate the lucrative fentanyl market. Fentanyl increasingly displaced heroin on the underground market, causing record numbers of overdoses around the world. In 2018, fentanyl and similar synthetic drugs accounted for nearly half of the 67,367 drug overdose deaths in the US. This year, overdoses have rocketed during the coronavirus pandemic, with more than 40 US states reporting an increase in drug mortality rates – particularly from synthetic opioids like fentanyl. In theory, sales of precursors are highly regulated. In reality, the extent of the problem is revealed with a simple Google search. Entering keywords for fentanyl precursors quickly leads you to the social network Pinterest, where – nestled between wedding moodboards and home decor inspiration – are posts from Chinese companies offering fentanyl precursors for export – many directed towards Mexico.

Note: Pharmaceutical executives have been caught bribing doctors to prescribe fentanyl-containing painkillers. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Sperm counts have been dropping; infant boys are developing more genital abnormalities; more girls are experiencing early puberty; and adult women appear to be suffering declining egg quality and more miscarriages. It's not just humans. Scientists report genital anomalies in a range of species, including unusually small penises in alligators, otters and minks. In some areas, significant numbers of fish, frogs and turtles have exhibited both male and female organs. Experts say the problem is a class of chemicals called endocrine disruptors, which mimic the body's hormones and thus fool our cells. This is a particular problem for fetuses as they sexually differentiate early in pregnancy. Endocrine disruptors can wreak reproductive havoc. These endocrine disruptors are everywhere: plastics, shampoos, cosmetics, cushions, pesticides, canned foods and A.T.M. receipts. They often aren't on labels and can be difficult to avoid. Chemical companies ... lobby against even safety testing of endocrine disruptors, so that we have little idea if products we use each day are damaging our bodies or our children. Still, the Endocrine Society, the Pediatric Endocrine Society, the President's Cancer Panel and the World Health Organization have all warned about endocrine disruptors, and Europe and Canada have moved to regulate them. But in the United States, Congress and the Trump administration seemed to listen more to industry lobbyists than to independent scientists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.

It's not often that a place like Harvard Medical School gets an F – particularly when rivals Stanford, Columbia and the University of Pennsylvania are pulling A's and B's. But that's what happened recently when the members of the increasingly influential – and increasingly noisy – American Medical Student Association (AMSA) decided to grade 150 med schools on just how much money and gifts they're collecting from drug companies. The more goodies a school is vacuuming up from the industry, the worse its grade. It turns out that many professors and instructors are, legally, on the dole as well, and students are beginning to worry that what they're being taught is just as one-sided as what patients are being prescribed. Harvard, at the moment, is at the center of it. Of Harvard's 8,900 professors and lecturers, 1,600 admit that either they or a family member have had some kind of business link to drug companies – sometimes worth hundreds of thousands of dollars – that could bias their teaching or research. Additionally, pharma contributed more than $11.5 million to the school last year for research and continuing-education classes. And while Harvard might be the highest-profile name that was posted on AMSA's grade list, it was hardly the only one that flunked: 40 out of the 150 schools surveyed received F's; only 22 got an A or B. Harvard has convened a 19-member committee ... to review its pharma policy, though the university is hedging on whether it actually plans to change the way it operates.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

A congressional report found many of the products made by the country's largest commercial baby food manufacturers contain significant levels of toxic heavy metals, including arsenic, lead, cadmium and mercury, which can endanger infant neurological development. The report ... from the House Oversight Committee's subcommittee on economic and consumer policy found heavy metals in rice cereals, sweet potato puree, juices and sweet snack puffs made by some of the most trusted names in baby food. Gerber, Beech-Nut, HappyBABY (made by Nurture) and Earth's Best Organic baby foods (made by Hain Celestial Group) complied with the committee's request to submit internal testing documents. Campbell Soup, which sells Plum Organics baby foods, Walmart (its private brand is Parent's Choice) and Sprout Foods declined to cooperate. Although there are no maximum arsenic levels established for baby food ... the FDA has set the maximum allowable levels in bottled water at 10 ppb of inorganic arsenic. Hain ... used many ingredients in its baby foods with as much as 309 ppb of arsenic. Lead levels in baby foods should not exceed 1 ppb. Beech-Nut used ingredients containing as much as 886.9 parts per billion of lead. In addition, Gerber used carrots containing as much as 87 ppb of cadmium and Nurture sold baby foods with as much as 10 ppb of mercury. And even when baby foods tested over companies' internal limits for these heavy metals, they were sold anyway.

Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.

Rep. Katie Porter on Friday published a damning report revealing the devastating effects of Big Pharma mergers and acquisitions on U.S. healthcare, and recommending steps Congress should take to enact "comprehensive, urgent reform" of an integral part of a broken healthcare system. The report, entitled Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients, begins by noting that "in just 10 years, the number of large, international pharmaceutical companies decreased six-fold, from 60 to only 10." While pharmaceutical executives often attempt to portray such consolidation as a means to increase operational efficiency, the report states that "digging a level deeper 'exposes a troubling industry-wide trend of billions of dollars of corporate resources going toward acquiring other pharmaceutical corporations with patent-protected blockbuster drugs instead of putting those resources toward' discovery of new drugs." Big pharmaceutical companies are not responsible for most major breakthroughs. Rather, innovation is driven in small firms, which are often spun off of taxpayer-funded academic research. These small labs are then purchased by giant firms. Instead of producing lifesaving drugs for diseases with few or no cures, large pharmaceutical companies often focus on small, incremental changes to existing drugs in order to kill off generic threats to their government-granted monopoly patents. Mergers in the pharmaceutical industry have had an overall negative effect on innovation.

Note: The major media, sponsored largely by Big Pharma, completely failed to report on this important study. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Google's YouTube has ratcheted up censorship to a new level by removing two videos from a U.S. Senate committee. They were from a Dec. 8 Committee on Homeland Security and Governmental Affairs hearing on early treatment of Covid-19. One was a 30-minute summary; the other was the opening statement of critical-care specialist Pierre Kory. Dr. Kory is part of a world-renowned group of physicians who developed a groundbreaking use of corticosteroids to treat hospitalized Covid patients. His testimony at a May Senate hearing helped doctors rethink treatment protocols and saved lives. At the December hearing, he presented evidence regarding the use of ivermectin, a cheap and widely available drug that treats tropical diseases caused by parasites, for prevention and early treatment of Covid-19. He described a just-published study from Argentina in which about 800 health-care workers received ivermectin and 400 didn't. Not one of the 800 contracted Covid-19; 58% of the 400 did. Before being removed from YouTube and other websites, Dr. Kory's opening statement had been viewed by more than eight million people. Unfortunately, government health agencies don't share that interest in early treatment. A year into the pandemic, NIH treatment guidelines for Covid patients are to go home, isolate yourself and do nothing other than monitor your illness. The censors at YouTube have decided for all of us that the American public shouldn't be able to hear what senators heard.

Note: You can access the entire article free of charge on this webpage. Can it be any more blatant that facebook is in cahoots with big Pharma in not wanting cheap, effective treatments for COVID-19? Watch an excellent, eye-opening 14-minute interview with a facebook insider revealing how censorship works. Read about how Silicon Valley is shutting down even live streams by legitimate journalists. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and media manipulation from reliable major media sources.

The nursing home industry has been devastated by the coronavirus, with outbreaks killing thousands of elderly residents. But the health crisis presents operators with a potential financial upside. Patients with COVID-19 could be worth more than four times what homes are able to charge for long-term residents with relatively mild health issues. Some patient advocates and industry experts fear the premium pay available for coronavirus patients – and a simultaneous easing of regulations around transfers – could tempt some home operators to move out low-paying residents to bring in more lucrative COVID-19 patients, despite the obvious health risks to residents and staff. "There are probably some unscrupulous operators who would jump at this," said David Grabowski, a professor of healthcare policy at Harvard Medical School. A new Medicare reimbursement system that went into effect last fall pays nursing homes substantially more for new patients – including those released from a hospital – particularly for the first few weeks. Under those guidelines, COVID-19 patients can bring in upward of $800 per day. By contrast, facilities collect as little as $200 per day for long-term patients with dementia. Nursing homes have always had a financial incentive to attract the short-term patients ... Grabowski said. But the health risks for existing residents and staff are so high with COVID-19, Grabowski said, "I'd be a little suspicious of a low-quality nursing home that's jumping to the head of the line for this."

Note: Another excellent article presents more important questions on how this might skew death statistics for the coronavirus. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Americans are taking more medications than ever before. Nearly 60 to 70 percent of us take at least one prescribed drug. Meanwhile, new drug approvals have reached a 19-year high. There's no formal process for quantifying injuries, hospitalizations or even deaths caused by therapeutic drug use – which excludes overdose or misuse. "Risk management begins with measuring things accurately, so you know what the threats are and the ones where you should be paying attention," says Thomas J. Moore ... at the Institute for Safe Medication Practices. But he notes that there's no system in place or accepted methodology for developing these tallies for prescription drugs, unlike with overdoses. Health providers and consumers are encouraged to report adverse drug reactions to the Food and Drug Administration. But the FDA says it's unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use. A ... recent analysis estimates 128,000 Americans die each year as a result of taking medications as prescribed. "By far the greatest number of [prescription drug-related] hospitalizations and deaths occur from drugs that are prescribed properly by physicians and taken as directed," says Donald Light ... lead author of a 2013 paper that detailed the estimate, entitled "Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs." "About 2,460 people per week are estimated to die from drugs that were properly prescribed," says Light.

Note: According to some studies, medical errors including adverse drug reactions may be the third leading cause of death in the US. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Throughout my career as a psychiatrist, I have found, on a clinical and scientific basis, psychiatric drugs do much more harm than good. My professional website (www.breggin.com) began as an attempt to present my scientific research. At the time that I started my reform efforts in the early 1970s, I was nearly alone among psychiatrists or any other professionals in standing up to the pharmaceutical industry, the electroshock industry, the American Psychiatric Association, the AMA, and other members of what I defined as the "psychopharmaceutical complex." When taken for months or years, all psychiatric drugs can seriously damage the brain, prevent recovery, and ruin the individual's quality of life. The psychiatric model of human suffering has caused untold damage to hundreds of millions of victims of involuntary treatment, psychiatric hospitals, drugs and electroshock. It has also set back civilization by undermining Western traditions of individuality, personal responsibility, and love. It has convinced modern society that emotional suffering is based in so-called biochemical imbalances when in reality it is rooted in a complex combination of human nature, individual experience and choice-making, and societal influences. This flawed biological model ignores all the important realities in human life from the dreadful effects of childhood trauma and adult disappointment and loss to the importance of living by worthwhile principles and ideals.

Note: Learn about Dr. Breggin's key role in stopping lobotomies and much more in this informative interview. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

US-based pharmaceutical giant Pfizer has made the first compensation payment to Nigerian families affected by a controversial drug trial 15 years ago. It paid $175,000 (Ł108,000) each to four families in the first of a series of payments it is expected to make. The payouts are part of an out-of-court settlement reached in 2009. In 1996, 11 children died and dozens were left disabled after Pfizer gave them the experimental anti-meningitis drug, Trovan. The payouts were made to the parents of four of the children who died. Their parents told the BBC they welcomed the payment, but it would not replace the loss of their loved ones. The children were part of a group of 200 given the drug during a meningitis epidemic in the northern city of Kano as part of a medical trial comparing Trovan's effectiveness with the established treatment. For years Pfizer maintained that meningitis - not the drug - caused the deaths and disabilities. But after a lengthy and expensive litigation process, it reached a settlement with the Kano government in northern Nigeria. The trials were carried out in Kano and the state government fought Pfizer on behalf of victims and their families. It has taken two years and DNA tests to establish who is entitled to payments, the BBC's Jonah Fisher in Lagos says. It could take another year for payments to be concluded, he says. Pfizer also agreed to sponsor health projects in Kano as well as creating a fund of $35m to compensate those affected.

Note: A BMJ article about this case states, "The families allege that the company failed to tell them that their children were being enrolled in an experimental drug trial and that free, effective treatment was available ... at the same hospital. Five children in the trovafloxacin arm and six in the ceftriaxone arm died, according to Pfizer." For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.